This post was originally published on this site
https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/11/1024/512/wegovy.jpg?ve=1&tl=1The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.